Sickle cell disease in a carrier with pyruvate kinase deficiency

Hematology

Volumn 13, Issue 6, 2008, Pages 369-372

  Alli, Nazeer ^a   Coetzee, Marius ^b   Louw, Vernon ^b   van Rensburg, Ben ^b   Rossouw, Gerrit ^b   Thompson, Lisa ^c   Pissard, Serge ^d   Thein, Swee Lay ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Pyruvate kinase deficiency; Sickle trait

Indexed keywords

BETA GLOBIN; ERYTHROPOIETIN; HEMOGLOBIN S; PYRUVATE KINASE; OXYGEN;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; ELECTROPHORESIS; ENZYME DEFICIENCY; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GHANA; GLOMERULOSCLEROSIS; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LEG ULCER; OXYGEN AFFINITY; PRIORITY JOURNAL; PYRUVATE KINASE DEFICIENCY; SEPSIS; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; UTERUS MYOMA; ADULT; ENZYMOLOGY; GENETICS; HETEROZYGOTE; METABOLISM; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE;

ADULT; ANEMIA, SICKLE CELL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HETEROZYGOTE; HUMANS; MUTATION, MISSENSE; OXYGEN; PYRUVATE KINASE;

EID: 60849083561     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453308X343536     Document Type: Article

References (15)

1. Serjeant GR. The emerging understanding of sickle cell disease. Br J Haematol 2001; 112: 3-18.
2. Noguchi C, Schechter AN, Rodgers GP. Sickle cell disease pathophysiology. In: Higgs DR, Weatherall DJ. (ed) Baillière's Clinical Haematology: The Haemoglobinopathies. London: Baillière Tindall, 1993; 57-91.
3. Kark JA, Ward FT. Exercise and hemoglobin S. Semin Hematol 1994; 31: 181-225.
4. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987; 317: 781-787.
5. Gitlin SD, Thompson CB. Non-altitude-related splenic infarction in a patient with sickle cell trait. Am J Med 1989; 87: 697-698.
6. Lane PA, Githens JH. Splenic syndrome at mountain altitudes in sickle cell trait. Its occurrence in nonblack persons. JAMA 1985; 253: 2251-2254.
7. Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol 2004; 26: 159-176.
8. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 2000; 95: 360-362.
9. Pissard S, Max-Audit I, Skopinski L et al. Pyruvate kinase deficiency in France: A 3-year study reveals 27 new mutations. Br J Haematol 2006; 133: 683-689.
10. Huisman TH, Carver MF, Efremov GD. A Syllabus of human Hemoglobin Variants, 2nd ed. Augusta. GA: The Sickle Cell Anemia Foundation, 1998.
11. Monplaisir N, Merault G, Poyart C et al. Hemoglobin S antilles: A variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci USA 1986; 83: 9363-9367.
12. Geva A, Clark JJ, Zhang Y, Popowicz, A, Manning JM, Neufeld EJ. Hemoglobin Jamaica plain-a sickling hemoglobin with reduced oxygen affinity. N Engl J Med 2004; 351: 1532-1538.
13. Adams JG, Heller P. Hemoglobin Arlington Park. A new hemoglobin variant with two amino acid substitutions in the beta chain. Hemoglobin 1977; 1: 419-426.
14. Zanella A, Fermo E, Bianchi P, Valentini G. Red cell. pyruvate kinase deficiency: Molecular and clinical aspects. Br J Haematol 2005; 130: 11-25.
15. Cohen-Solal M, Prehu C, Wajcman H et al. A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry). Br J Haematol 1998; 103: 950-956.